These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 31211964

  • 1. Sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: impact on fecal incontinence symptoms and sexual function.
    Andy UU, Amundsen CL, Honeycutt E, Markland AD, Dunivan G, Dyer KY, Korbly NB, Bradley M, Vasavada S, Mazloomdoost D, Thomas S, NICHD Pelvic Floor Disorders Network.
    Am J Obstet Gynecol; 2019 Nov; 221(5):513.e1-513.e15. PubMed ID: 31211964
    [Abstract] [Full Text] [Related]

  • 2. OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial.
    Amundsen CL, Richter HE, Menefee SA, Komesu YM, Arya LA, Gregory WT, Myers DL, Zyczynski HM, Vasavada S, Nolen TL, Wallace D, Meikle SF.
    JAMA; 2016 Oct 04; 316(13):1366-1374. PubMed ID: 27701661
    [Abstract] [Full Text] [Related]

  • 3. Refractory urgency urinary incontinence treatment in women: impact of age on outcomes and complications.
    Komesu YM, Amundsen CL, Richter HE, Erickson SW, Ackenbom MF, Andy UU, Sung VW, Albo M, Gregory WT, Paraiso MF, Wallace D, Eunice Kennedy Shriver National Institute of Child Health and Human Development Pelvic Floor Disorders Network.
    Am J Obstet Gynecol; 2018 Jan 04; 218(1):111.e1-111.e9. PubMed ID: 29031894
    [Abstract] [Full Text] [Related]

  • 4. Cost-Effectiveness of Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial.
    Harvie HS, Amundsen CL, Neuwahl SJ, Honeycutt AA, Lukacz ES, Sung VW, Rogers RG, Ellington D, Ferrando CA, Chermansky CJ, Mazloomdoost D, Thomas S.
    J Urol; 2020 May 04; 203(5):969-977. PubMed ID: 31738113
    [Abstract] [Full Text] [Related]

  • 5. Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized Trial.
    Amundsen CL, Komesu YM, Chermansky C, Gregory WT, Myers DL, Honeycutt EF, Vasavada SP, Nguyen JN, Wilson TS, Harvie HS, Wallace D, Pelvic Floor Disorders Network.
    Eur Urol; 2018 Jul 04; 74(1):66-73. PubMed ID: 29482936
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence.
    Richter HE, Amundsen CL, Erickson SW, Jelovsek JE, Komesu Y, Chermansky C, Harvie HS, Albo M, Myers D, Gregory WT, Wallace D, NICHD Pelvic Floor Disorders Network.
    J Urol; 2017 Oct 04; 198(4):890-896. PubMed ID: 28501541
    [Abstract] [Full Text] [Related]

  • 8. Urinary Biomarkers in Women with Refractory Urgency Urinary Incontinence Randomized to Sacral Neuromodulation versus OnabotulinumtoxinA Compared to Controls.
    Richter HE, Moalli P, Amundsen CL, Malykhina AP, Wallace D, Rogers R, Myers D, Paraiso M, Albo M, Shi H, Nolen T, Meikle S, Word RA, Pelvic Floor Disorders Network.
    J Urol; 2017 Jun 04; 197(6):1487-1495. PubMed ID: 28089729
    [Abstract] [Full Text] [Related]

  • 9. Comparison of OnabotulinumtoxinA versus sacral neuromodulation for refractory urinary urge incontinence: A systematic review and meta-analysis of randomized controlled trials.
    Niu HL, Ma YH, Zhang CJ.
    Int J Surg; 2018 Dec 04; 60():141-148. PubMed ID: 30415088
    [Abstract] [Full Text] [Related]

  • 10. Seminal papers in urology: two-year outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for refractory urgency urinary incontinence: a Randomized Trial.
    Abd Wahab HHB, O'Callaghan M.
    BMC Urol; 2024 Jan 16; 24(1):16. PubMed ID: 38229041
    [Abstract] [Full Text] [Related]

  • 11. Sexual Activity After Bariatric Surgery: A Prospective Monocentric Study Using the PISQ-IR Questionnaire.
    Treacy PJ, Mazoyer C, Falagario U, Iannelli A.
    J Sex Med; 2019 Dec 16; 16(12):1930-1937. PubMed ID: 31678099
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sexual function in women with anal incontinence using a new instrument: the PISQ-IR.
    Pauls RN, Rogers RG, Parekh M, Pitkin J, Kammerer-Doak D, Sand P.
    Int Urogynecol J; 2015 May 16; 26(5):657-63. PubMed ID: 25392184
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Minimal Clinically Important Difference (MCID) for the Pelvic Organ Prolapse-Urinary Incontinence Sexual Function Questionnaire - IUGA Revised (PISQ-IR).
    Pruijssers B, van der Vaart L, Milani F, Roovers JP, Vollebregt A, van der Vaart H.
    J Sex Med; 2021 Jul 16; 18(7):1265-1270. PubMed ID: 34144912
    [Abstract] [Full Text] [Related]

  • 16. Sacral neuromodulation for combined faecal and urinary incontinence following obstetric anal sphincter injury.
    Rydningen MB, Riise S, Wilsgaard T, Lindsetmo RO, Norderval S.
    Colorectal Dis; 2018 Jan 16; 20(1):59-67. PubMed ID: 28727899
    [Abstract] [Full Text] [Related]

  • 17. Does sacral nerve stimulation improve global pelvic function in women?
    Jadav AM, Wadhawan H, Jones GL, Wheldon LW, Radley SC, Brown SR.
    Colorectal Dis; 2013 Jul 16; 15(7):848-57. PubMed ID: 23451900
    [Abstract] [Full Text] [Related]

  • 18. Effects of preoperative intravaginal estrogen on pelvic floor disorder symptoms in postmenopausal women with pelvic organ prolapse.
    Rahn DD, Richter HE, Sung VW, Hynan LS, Pruszynski JE.
    Am J Obstet Gynecol; 2023 Sep 16; 229(3):309.e1-309.e10. PubMed ID: 37244454
    [Abstract] [Full Text] [Related]

  • 19. Polish translation and validation of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR).
    Grzybowska ME, Piaskowska-Cala J, Wydra DG.
    Int Urogynecol J; 2019 Jan 16; 30(1):55-64. PubMed ID: 29288345
    [Abstract] [Full Text] [Related]

  • 20. German translation and validation of the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire-IUGA revised (PISQ-IR).
    Trutnovsky G, Nagele E, Ulrich D, Aigmüller T, Dörfler D, Geiss I, Reinstadler E, Angleitner-Flotzinger J, Ries JJ, Bjelic-Radisic V, Austrian Urogynecology Working Group.
    Int Urogynecol J; 2016 Aug 16; 27(8):1235-44. PubMed ID: 26883366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.